Clinical Trial Update: An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)

View source ↗

Summary

This is a completed observational study assessing the use and safety of Raptiva (efalizumab) during pregnancy in women with psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Raptiva (efalizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Psoriasis, Pregnancy | Status: COMPLETED